PIK3CA and breast cancer: At present, the overexpression of MCM has been detected in various cancer tissues and cancer cell lines, including squamous cell lung carcinoma [12], kidney cancer [13], prostate carcinoma [14], BC [15], digestive system tumors [16–18], brain tumors [19], and lymphomas [20].